Core biopsy as a tool in planning the management of invasive breast cancer

被引：8

作者：

Deshpande A. ^{[1
]}

Garud T. ^{[2
]}

Holt S.D. ^{[3
]}

机构：

[1] Department of General Surgery, University Hospital, Birmingham

[2] Department of General Surgery, North Tees University Hospital, Stockton-on-Tees

[3] Department of Surgery, Prince Phillip Hospital, Llanelli

来源：

World Journal of Surgical Oncology | / 3卷 / 1期

关键词：

Breast Cancer; Core Biopsy; Fine Needle Aspiration Cytology; Final Grade; Nottingham Prognostic Index;

D O I：

10.1186/1477-7819-3-1

中图分类号：

学科分类号：

摘要：

Background: Core biopsy is a method of choice for the triple assessment of breast disease as it can reliably distinguish between benign and malignant tumours, between in-situ and invasive cancers and can be useful to assess oestrogen receptor status. This study was carried out to assess the reliability of core biopsy in predicting the grade and type of cancer accurately as obtaining this information can influence initial therapeutic decisions. Patients and methods: A total of 105 patients who had invasive breast carcinoma diagnosed by core biopsy in year 2001 and who subsequently underwent surgical management were included. The core biopsy results were compared with final histology with the help of kappa statastics. Results: A moderate level of agreement between the predicted grades and final grades was noted (kappa = 0.585). The agreement was good between predicted and final type of tumour (kappa = 0.639). Conclusions: Core biopsy as a predictor of grade and type has limited use at present. We suggest that initial clinical decisions should not be based on the results of core biopsy. © 2005 Deshpande et al; licensee BioMed Central Ltd.

引用

页数：4

共 31 条

[1]

Farshid G., Rush G., The use of fine-needle aspiration cytology and core biopsy in the assessment of highly suspicious mammographic calcifications: Analysis of outcome for 182 lesions detected in the setting of a population-based breast cancer screening program, Cancer, 99, pp. 357-364, (2003)

[2]

Fersis N., Smyczek-Garagya B., Krainick U., Mielke G., Muller-Schimpfle M., Keisel L., Wallweiner D., Clinical experience with large-core needle biopsies of the breast and treatment and evaluation of histopathological results, Zentralbl. Gynakol., 123, pp. 132-135, (2001)

[3]

Clarke D., Sudhakaran N., Gately C.A., Replace the fine needle aspiration cytologywith automated core biopsy in triple assessment of breast cancers, Ann. R. Coll. Surg. Engl., 83, pp. 110-112, (2001)

[4]

Sun W., Li A., Abreo F., Turbat-Herrera E., Grafton W.D., Comparison of fine needle aspiration cytology and core biopsy for diagnosis of breast cancer, Diagn. Cytopathol., 24, pp. 421-425, (2001)

[5]

Crowe Jr. J.P., Rim A., Patrick R.J., Rybicki L.A., Grundfest-Broniatowski S.F., Kim J.A., Lee K.B., Does core needle breast biopsy accurately reflect breast pathology?, Surgery, 134, pp. 523-528, (2003)

[6]

McIntosh S.A., Panchalingam L., Payne S., Miller I.D., Sarkar T.K., Hutcheon A.W., Heys S.D., Freehand core biopsy in breast cancer: An accurate predictor of tumour grade following neo-adjuvant chemotherapy?, Breast, 11, pp. 496-500, (2002)

[7]

du Toit R.S., Locker A.P., Ellis I.O., Elston C.W., Nicholson R.I., Blamey R.W., Invasive lobular carcinomas of the breast- the prognosis of histopathological subtypes, Br. J. Cancer, 60, pp. 605-609, (1989)

[8]

Fisher E.R., Redmond C., Fisher B., Prognostic factors in NSABP studies of women with node negative breast cancer. National Surgical Adjuvant Breast and Bowel project, Monogr. Natl. Cancer Inst., 11, pp. 151-158, (1992)

[9]

Dixon J.M., Page D.L., Anderson T.J., Lee D., Elton R.A., Stewart H.J., Forest A.P., Long-term survivors after breast cancer, Br. J. Surg., 72, pp. 445-448, (1985)

[10]

Haybittle J.L., Blamey R.W., Elston C.W., Johnson J., Doyle P.J., Campbell F.C., Nicholson R.I., Griffiths K., A prognostic index in primary breast cancer, Br. J. Cancer, 45, pp. 361-365, (1982)

← 1 2 3 4 →